IGC icon

IGC Pharma
IGC

Overview Fund Activity

32 hedge funds and large institutions have $7.9M invested in IGC Pharma in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 3 closing their positions.

Holders
32
Holders Change
+3
Holders Change %
+10.34%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
12
Closed
3
Calls
$823K
Puts
$687K
Net Calls
+$136K
Net Calls Change
-$488K

Top Buyers

1
Mirae Asset Global Investments
1
Mirae Asset Global Investments
South Korea
$599K
2
IEFM
2
IQ EQ Fund Management
Ireland
$2.09M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$646K
4
Bank of America
4
Bank of America
North Carolina
$144K
5
VIA
5
Vident Investment Advisory
Georgia
$83K

Top Sellers

1
VF
1
Virtu Financial
New York
$26K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$437K
3
BCM
3
Bridgeway Capital Management
Texas
$206K
4
PCM
4
Penserra Capital Management
California
$0
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CG
26
Cutler Group
California
$6K -$2.57K -1,757 -30%
GWM
27
Geneos Wealth Management
Colorado
$4K – – –
Morgan Stanley
28
Morgan Stanley
New York
$2K +$1.29K +910 +182%
BMD
29
Better Money Decisions
New Mexico
$1K – – –
PCM
30
Penserra Capital Management
California
– -$98K -56,068 Closed
T. Rowe Price Associates
31
T. Rowe Price Associates
Maryland
– -$71K -43,000 Closed
Squarepoint
32
Squarepoint
New York
– -$20K -12,182 Closed
1
2